Diabetes Portfolio: Treatment identification tool

This case study describes how pharmaceutical company AstraZeneca developed a 3D virtual consulting room to help demonstrate how its six Type-2 diabetes (T2D) products can provide patients with personalised treatment options.

Diabetes Portfolio: Treatment identification tool

Helen Peterkin

Campaign details

Brand owner: AstraZenecaLead agency: Ogilvy DigitalHealthContributing agency: Ogilvy DigitalHealthBrand: Diabetes PortfolioCountry: SpainIndustry Promotions to the medical professionChannels used: Direct marketing, Events and experiential, Other and ambient mediaMedia budget: Up to $500k

Executive summary

This case study describes how pharmaceutical company AstraZeneca developed a 3D virtual consulting room to help demonstrate how its six Type-2 diabetes (T2D) products can provide patients with personalised treatment options, an approach recommended by the ADA and EASD,*two world-leading diabetes...

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands